Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 85, Issue 1, 1999, Pages 7-11

  Tanos, Vasilios ^a   Prus, Diana ^a   Ayesh, Suhail ^b   Weinstein, Daniel ^a   Tykocinski, Mark L ^c   De Groot, Nathan ^d   Hochberg, Abraham ^d   Ariel, Iiana ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Al Makassed Islamic Charitable Society Hospital   (Israel)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Genomic imprinting; H19; Ovarian neoplasm; Serous carcinoma; Tumor marker

Indexed keywords

POLYADENYLATED RNA; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; CANCER STAGING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOCHEMISTRY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENOME IMPRINTING; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RNA ANALYSIS;

EID: 0033034825     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00275-9     Document Type: Conference Paper

References (27)

1. Solter D. Differential imprinting and expression of maternal and paternal genomes. Annu Rev Genet. 122:1988;127-146.
2. Tycko B. Genomic imprinting: mechanism and role in human pathology. Am J Pathol. 144:1944;431-443.
3. Surani M.A. Genomic imprinting: developmental significance and molecular mechanism. Curr Opin Genet Dev. 1:1991;241-246.
4. De Groot N., Hochberg A. Gene imprinting during placental and embryonic development. Mol Reprod Dev. 36:1993;390-406.
5. Hochberg A., GoniK B., Goshen R., de Groot N. A growing relationship between genomic imprinting and tumorigenesis. Cancer Genet Gytogenet. 73:1994;82-83.
6. Looijenga L.H.J., Verkert A.J.M.H., de Groot N., Hochberg A., Oosterhuis J.W. H19 in normal development and neoplasia. Mol Reprod Dev. 46:1997;419-439.
7. Zemel S., Bartolomei M.S., Tilghman S.M. Physical linkage of the mammalian imprinted genes H19 and insulin-like growth factor 2. Nature Genet. 2:1992;61-65.
8. DeChiara T., Robertson E., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:1991;849-859.
9. Leighton P.A., Ingram R.S., Eggenschwiler J., Efstratiadis A., Tilghman S.M. Disruption of imprinting caused by deletion of the H19 region in mice. Nature. 375:1995;34-39.
10. Goshen R., Rachmilewitz J., Schneider T., de Groot N., Ariel I., Palti Z., Hochberg A. The expression of H19 and IGF2 genes during human embryogenesis and placental development. Mol Reprod Dev. 34:1993;374-379.
11. Brannan C.I., Dees E.C., Ingram R.S., Tilghman S.M. The product of the H19 gene may functon as an RNA. Mol Cell Biol. 10:1990;28-36.
12. Lustig O., Ariel I., IIan J., Lev-Lehman E., de Groot N., Hochberg A. Expression of the imprinted H19 gene in the human fetus. Mol Reprod Dev. 38:1994;239-246.
13. Ariel I., Ayesh S., Perlman E.J., Pizov G., Schneider T., Erdmann V.A., Schneider T., Lustig-Yariv O., de Groot N., Hochberg A. The product of the imprinted H19 gene is an oncofetal RNA. J Clin Pathol Mol Pathol. 50:1997;34-44.
14. Ariel I., Weinstein D., Voutilainen R., Schneider T., Lusting-Yariv O., de Groot N., Hochberg A. Genomic imprinting and the endometrial cycle. The expression of the imprinted gene H19 in the human female reproductive organs. Diagn Mol Pathol. 6:1997;17-25.
15. Kiechle-Schwartz M., Bauknecht T., Wienker T., Walz L., Pfleiderer A. Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer: positive correlation with grade of differentiation. Cancer. 72:1993;2423-2432.
16. Enomoto T., Weghorst C.M., Inoue M., Tanizawa O., Rice J.M. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the ovary. Am J Pathol. 139:1991;777-785.
17. Hass M., Isakov J., Howell S.B. Evidence against ras activation in human ovarian carcinomas. Mol Biol Med. 4:1987;265-275.
18. Serova O.M. Amplification of c-myc proto-oncogne in primary tumors, metastases and blood leukocytes of patients with ovarian cancer. Eksper Onkol. 9:1987;25-27.
19. Baker V.V., Borst M.P., Dixon D., Hatch K.D., Shingleton H.M., Miller D. c-myc amplification in ovarian cancer. Gynecol Oncol. 38:1990;340-342.
20. Milner B.J., Allan L.A., Eccles D.M., Kitchener H.C., Leonard R.C., Kelly K.F., Parkin D.E., Haites N.E. p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res. 539:1993;2128-2132.
21. Kohler M.F., Marks J.R., Wiseman R.W., Jacobs I.J., Davidoff A.M., Clarke-Pearson D.L., Soper J.T., Bast R.C. Jr., Berchuck A. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst. 85:1993;1513-1519.
22. Smith S.A., Easton D.F., Evans D.G., Fonder B.A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet. 2:1992;128-131.
23. Feunteun J., Narod S.A., Lynch H.T., Watson P., Conway T., Lynch J., Parbusingh J., O'Connell P, White R., Lenoir Gm A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Human Genet. 52:1993;736-742.
24. Bombard A.T., Fields A.L., Aufox S., Ben-Yishay M. The genetics of ovarian cancer: an assessment of current screening protocols and recommendations for counceling families as risk. Clin Obstet Gynecol. 39:1996;860-872.
25. Katz A.E., de Vries G.M., Begg M.D., Raffo A.G., Cama C., O'Toole K., Buttyan R., Benson M.C., Olsson C.A. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer. 75:1995;1642-1648.
26. Lehrer S., Terk M., Piccoli S.P., Song H.K., Lavagnini P., Lauder A.A. Reverse transcriptase-polymerase chain reaction for prostate specific antigen may be a prognostic indicator in breast cancer. Br J Cancer. 74:1996;871-873.
27. Giannoukakis N., Deal C., Paquette J., Kukuvitis A., Polychronakos C. Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression. Biochem Biophys Res Commun. 220:1996;1014-1019.